FDA Inspection 1047488 — AstraZeneca Pharmaceuticals, LP
The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on March 5, 2018 in Coppell, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Coppell, TX (United States)